Aprea Therapeutics Inc.

NASDAQ: APRE · Real-Time Price · USD
1.71
0.02 (1.18%)
At close: Aug 15, 2025, 3:59 PM
1.67
-2.54%
After-hours: Aug 15, 2025, 07:38 PM EDT

Aprea Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
22.85M 21.61M 28.79M 53.08M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
40.17K 40.72K n/a n/a
Other Long-Term Assets
281.66K n/a n/a n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
726.25K 914.27K 1.37M n/a
Total Current Assets
23.58M 22.52M 30.15M 56.58M
Property-Plant & Equipment
81.52K 88.36K 2.32K 239.05K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
403.35K 129.08K 2.32K 239.05K
Total Assets
23.98M 22.65M 30.16M 56.82M
Account Payables
1.35M 1.67M 842.75K 1.77M
Deferred Revenue
n/a 528.97K n/a n/a
Short-Term Debt
n/a n/a n/a 190.47K
Other Current Liabilities
465.01K 1.17M 960.36K 3.74M
Total Current Liabilities
3.36M 4.39M 3.2M 7.32M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
1.31M 1.31M 1.31M n/a
Total Long-Term Liabilities
1.31M 1.31M 1.31M 1.96M
Total Liabilities
4.67M 4.39M 4.51M 7.32M
Total Debt
n/a n/a n/a 190.47K
Common Stock
5.48K 3.74K 2.65K 21.86K
Retained Earnings
-321.04M -308.08M -293.8M -181.13M
Comprehensive Income
-10.63M -10.61M -10.62M -10.36M
Shareholders Equity
19.31M 18.26M 25.64M 49.51M
Total Investments
40.17K 40.72K n/a n/a